Naftopidil dispersible tablet and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A kind of technology of nafidil and dispersible tablet, applied in the field of nafidil dispersible tablet and preparation thereof
Inactive Publication Date: 2013-04-03
NINGXIA DUOWEI PHARMA
View PDF0 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, naftopidil bulk drug is insoluble in water, has low gastrointestinal absorption rate and low bioavailability (the gastrointestinal absorption rate of rats is 70%, and the bioavailability of rats and dogs is 10%), so , the bioavailability of ordinary naftopidil tablets is low, which is not conducive to human body absorption
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0060] Embodiment 1: Containing the dispersible tablet preparation of 12.5mg naftopidil
[0061] Prepare raw materials by following weight ratio:
[0063] (1) Grind naftopidil, lactose, hydroxymethyl starch sodium, methyl microcrystalline cellulose, hydroxypropyl cellulose, talcum powder, and sodium saccharin separately, and pass through a 100-mesh sieve;
[0064] (2) Grind and mix the sodium saccharin and the same amount of naftopidil until the visual color is consistent, and then grind and mix the above mixed powder with the remaining naftopidil until the visual color is consistent;
[0065] (3) Mix the mixed powder obtained in the above (2) with lactose, carboxymethyl starch sodium, microcrystalline cellulose, hydroxypropyl cellulose, and talcum p...
Embodiment 2
[0067] Embodiment 2: the dispersible tablet preparation containing 25mg naftopidil
[0068] Prepare raw materials by following weight ratio:
[0074] The preparation method is the same as in Example 1.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a naftopidil dispersible tablet and a preparation method thereof. The naftopidil comprises the following drugs in parts by weight: 12.5-30 parts of naftopidil, 0.5-2 parts of sweetening agent, 10-15 parts of talcum powder, 20-25 parts of sugar, 15-20 parts of explotab, 25-35 parts of cellulose, 17-25 parts of hydroxy propyl cellulose, 0.05-0.1 part of poloxamer and 0.5-1.0 part of magnesium stearate. The naftopidil dispersible tablet is used for treating prostatic hyperplasia, and has the advantages that the disintegration speed and the absorbing speed are quick, the drug dissolution rate and the bioavailability are high, the blood concentration can be stable quickly, and the clinical treatment effect of the prostatic hyperplasia can be improved.
Description
field of invention [0001] The invention belongs to the technical field of medicines, in particular to a naftopidil dispersible tablet and a preparation method thereof. Background technique [0002] Benign prostatic hyperplasia (BPH) is a common disease in elderly men. With the acceleration of population aging, the incidence of benign prostatic hyperplasia is also increasing. According to reports, 50% of men aged 50-60, 60% of men aged 60-70, 70% of men aged 70-80, and 88% of men over 80 years old have different degrees of benign prostatic hyperplasia. May develop symptomatic BPH. [0003] BPH causes bladder neck obstruction, affects the normal function of the urinary system, produces varying degrees of voiding disorders, and eventually causes bladder and kidney lesions, resulting in damage to renal function and seriously affecting the quality of life of patients. In addition to the mechanical obstruction (static factor) caused by the enlarged prostate gland volume, the bla...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more